Last updated: 2026-10-14 08:19:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Whitehawk Therapeutics, Inc. (WHWK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.02, with a market capitalisation of $192.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.87 to $5.50. This page covers its latest market performance, valuation, price trends and company information.
$192.69M | |
$3.02 | |
$5.50 | |
$1.39 | |
$3.02 | |
1.00 | |
364.93K | |
-- | |
$5.50 | |
$1.87 | |
-- | |
-- |
Whitehawk Therapeutics, Inc. (WHWK) is trading at $3.02 in pre-market trading as of 2026-10-14 08:01:00, unchanged from the previous close of $3.02
Pre-market trading shows how investors are pricing WHWK before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Over the past seven days, Whitehawk Therapeutics, Inc. (WHWK) moved from $3.70 to $3.02, representing a decline of 18.38% ($0.68).
The stock traded between $3.00 and $3.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 349.38 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 31.7%
WHWK is currently trading at $3.02, placing it 31.7% of the way from its 52-week low of $1.87 to its 52-week high of $5.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Whitehawk Therapeutics, Inc. (WHWK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.